Skip to main content

Advertisement

SpringerLink
Log in

Clinical significance of nuclear factor (NF)-κB levels in urothelial carcinoma of the urinary bladder

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Nuclear factor (NF)-κB has been reported to be constitutively activated in various human neoplasms. However, its clinical significance in bladder urothelial carcinoma (UC) remains an unresolved issue. We conducted this study trying to elucidate the role of NFκB in bladder UC and its potential prognostic significance, by quantifying immunohistochemically the levels of p65/RelA expression in paraffin-embedded tissue from 116 patients. Some of the cases had previously been stained for cellular FLICE-like inhibitory protein (c-FLIP) and bcl-2. Seventy-four cases displayed concurrent cytoplasmic and nuclear immunoreactivity, whereas 18 only nuclear immunoexpression and 21 only cytoplasmic immunoexpression, and the remaining three cases were negative for p65/RelA. Nuclear p65/RelA expression was positively associated with tumour grade and T-category (p = 0.0001 in both cases). In addition, cytoplasmic p65/RelA expression was lower in advanced T-category (p = 0.0030). Moreover, p65/RelA nuclear expression was positively correlated with c-FLIP (p = 0.0109) and bcl-2 (p = 0.0452). p65/RelA nuclear expression adversely affected survival in both univariate and multivariate analysis in superficial (Ta–T1; p = 0.0010 and p = 0.0008) as well as in muscle-invasive carcinomas (T2–T4; p = 0.0004 and p = 0.0003). Our results demonstrate that NF-κB nuclear expression is correlated with histologic grade and T category in bladder UC. Moreover, NF-κB nuclear expression emerges as an independent prognosticator of adverse significance, conveying information beyond that obtained by standard clinicopathological prognosticators.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abdel-Latif MMM, O’Riodan J, Windle HJ, Carton E, Ravi N, Kelleher D, Reynolds JV (2004) NF-κB activation in esophageal adenocarcinoma. relationship to Barrett’s metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 239:491–499

    Article  PubMed  Google Scholar 

  2. Abdel-Mageed AB, Ghoniem GM (1998) Potential role of Rel/Nuclear factor-jB in the pathogenesis of interstitial cystitis. J Urol 160:2000

    Article  PubMed  CAS  Google Scholar 

  3. Baldwin AS (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14:649–683

    Article  PubMed  CAS  Google Scholar 

  4. Bours V, Dejardin E, Goujon-Letawe F, Merville MP, Castronovo V (1994) The NF-κB transcription factor and cancer: high expression of NF-κB and IκB-related proteins in tumour cell lines. Biochem Pharmacol 47:145–149

    Article  PubMed  CAS  Google Scholar 

  5. Chen FE, Ghosh G (1999) Regulation of DNA binding by Rel/NFκB transcription factors: structural reviews. Oncogene 18:6845–6852

    Article  PubMed  CAS  Google Scholar 

  6. Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP, Bours V (1999) Regulation of NF kappa B activity by I kappaB-related proteins in adenocarcinoma cells. Oncogene 18:2567–2577

    Article  PubMed  CAS  Google Scholar 

  7. Dhawan P, Singh AB, Ellis DL, Richmond A (2002) Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res 62:7335–7342

    PubMed  CAS  Google Scholar 

  8. Dolcet X, Llobet D, Pallares J, Matias-Guiu X (2005) NF-κB in development and progression of human cancer. Virchows Arch 5:475–482

    Article  CAS  Google Scholar 

  9. Eble JN, Young RH (1997) Carcinoma of the urinary bladder: a review of its diverse morphology. Semin Diagn Pathol 14:98–108

    PubMed  CAS  Google Scholar 

  10. Eble JN, Epstein JI, Seternhenn IA (2004) World Health Organization classification of tumours. Pathology and genetics, tumours of the urinary system and male genital track. IARC, Lyon, pp 89–115

    Google Scholar 

  11. Feinman R, Koury J, Thames M, Barlogie B, Epstein J, Siegel DS (1999) Role of NF- B in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 93:3044–3052

    PubMed  CAS  Google Scholar 

  12. Gasparian AV, Yao YJ, Kowalczyk D, Lyakh LA, Karseladze A, Slaga TJ, Budunova IV (2002) The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J Cell Sci 115:141–151

    PubMed  CAS  Google Scholar 

  13. Ghosh S, May M, Kopp EB (1998) NFκB and Rel proteins: evolutionary conserved mediators of immune responses. Annu Rev Immunol 16:225–260

    Article  PubMed  CAS  Google Scholar 

  14. Gilmore TD (2006) Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25(51):6680–6684

    Article  PubMed  CAS  Google Scholar 

  15. Giri DK, Aggarwal BB (1998) Constitutive activation of NF- B causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumour necrosis factor and reactive oxygen intermediates. J Biol Chem 273:14008–14014

    Article  PubMed  CAS  Google Scholar 

  16. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics 2000. CA Cancer J Clin 50:7–33

    Article  PubMed  CAS  Google Scholar 

  17. Hayashi S, Yamamoto M, Ueno Y, Ikeda K, Ohshima K, Soma G et al (2001) Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas. Neurol Med Chir (Tokyo) 41(4):187–195

    Article  CAS  Google Scholar 

  18. Horiguchi Y, Kuroda K, Nakashima J, Murai M, Umezawa K (2003) Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells. Expert Rev Anticancer Ther 6:793–798

    Article  Google Scholar 

  19. Izzo JG, Malhotra U, Wu TT, Ensor J, Luthra R, Lee JH, Swisher SG, Liao Z, Chao KS, Hittelman WN, Aggarwal BB, Ajani JA (2006) Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol 5:748–754

    Article  CAS  Google Scholar 

  20. Jacobson SH, Hylander B, Wretlind B, Brauner A (1994) Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function. Nephron 67(2):172–179

    Article  PubMed  CAS  Google Scholar 

  21. Kang S, Kim YB, Kim MH, Yoon KS, Kim JW, Park NH, Song YS, Kang D, Yoo KY, Kang SB, Lee HP (2005) Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. J Can Let 217(1):11–16

    Article  CAS  Google Scholar 

  22. Karashima T, Sweeney P, Kamat A, Huang S, Kim SJ, Bar-Eli M, McConkey DJ, Dinney CPN (2003) Nuclear factor-κB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin Cancer Res 9:2786–2797

    PubMed  CAS  Google Scholar 

  23. Karin M (1999) How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18(49):6867–6874

    Article  PubMed  CAS  Google Scholar 

  24. Karin M, Cao Y, Greten FR, Li AW (2002) NFκB in cancer: from innocent bystander to major culprit. Nat Rev Cancer 2:301–310

    Article  PubMed  CAS  Google Scholar 

  25. Korkolopoulou P, Konstantinidou AE, Christodoulou P, Patsouris E, Thomas-Tsangli E, Kapralos P, Davaris P (2000) Apoptosis in bladder carcinomas detected with monoclonal antibody to single-stranded DNA: relation to cell cycle regulators and survival. Urology 56(3):516–520

    Article  PubMed  CAS  Google Scholar 

  26. Korkolopoulou P, Christodoulou P, Lazaris A, Thomas-Tsagli E, Kapralos P, Papanikolaou A, Kalliteraki I, Davaris P (2001) Prognostic implications of aberrations in p16/pRb pathway in urothelial bladder carcinomas: a multivariate analysis including p53 expression and proliferation markers. Eur Urol 39(2):167–177

    Article  PubMed  CAS  Google Scholar 

  27. Korkolopoulou P, Lazaris AC, Konstantinidou AE, Kavantzas N, Patsouris E, Christodoulou P, Thomas-Tsagli E, Davaris P (2002) Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival. Eur Urol 41(3):274–283

    Article  PubMed  CAS  Google Scholar 

  28. Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA (2004) C-Flip expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correltations. J Urol 63(6):1198–1204

    Article  Google Scholar 

  29. Kruger S, Thorns C, Bohle A, Feller AC (2003) Prognostic significance of a grading system considering tumour heterogenetity in muscle invasive urothelial carcinoma of the urinary bladder. Int Urol Nephrol 35(2):169–173

    Article  PubMed  CAS  Google Scholar 

  30. La Vecchia C, Negri E, D’Avanzo B, Savoldelli R, Franceschi S (1991) Genital and urinary tract diseases and bladder cancer. Cancer Res 51:629–631

    PubMed  Google Scholar 

  31. Lessard L, Mes-Masson AM, Lamarre L, Wall L, Lattouf JB, Saad F (2003) NF-κB nuclear localization and its prognostic significance in prostate cancer. BJU Int 91:417–420

    Article  PubMed  CAS  Google Scholar 

  32. Levidou G, Korkolopoulou P, Nikiteas N, Tzanakis N, Thymara I, Saetta AA et al (2007) Expression of nuclear factor kappaB in human gastric carcinoma: relationship with IkappaBa and prognostic significance. Virchows Arch 450(5):519–527

    Article  PubMed  CAS  Google Scholar 

  33. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, Moldawer LL, Copeland EM 3rd, Mackay S (2001) Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery 2:363–369

    Article  Google Scholar 

  34. Mikulowski P, Hellsten S (2005) T1G1 urinary bladder carcinoma: Fact or fiction? Scand J Urol Nephrol 39:135–137

    PubMed  Google Scholar 

  35. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Sledge GW (1997) Constitutive activation of NF- B during progression of breast cancer to hormone-independent growth. Mol Cell Biol 17:3629–3639

    PubMed  CAS  Google Scholar 

  36. Osman I, Scher H, Zhang ZF, Soos TJ, Hamza R, Eissa S, Khaled H, Koff A, Cordon-Cardo C (1997) Expression of cyclin D1 but not cyclins E and A, is related to progression in bilharzial bladder cancer. Clin Cancer Res 3:2247–2251

    PubMed  CAS  Google Scholar 

  37. Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, Marumo K, Shimizu N, Murai M (2003) Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 24(3):377–384

    Article  PubMed  CAS  Google Scholar 

  38. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18(49):6853–6866

    Article  PubMed  CAS  Google Scholar 

  39. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Price BD (1999) Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18:7389–7394

    Article  PubMed  CAS  Google Scholar 

  40. Perkins ND (2000) The Rel/NF-kappa B family: friend and foe. Trends Biochem Sci 9:434–440

    Article  Google Scholar 

  41. Pryor JP (1973) Factors influencing the survival of patients with transitional cell tumours of the urinary bladder. Br J Urol 45:586–591

    PubMed  CAS  Google Scholar 

  42. Rayet B, Gelinas C (1999) Aberrant rel/nfkb genes and activity in human cancer. Oncogene 18(49):6938–6947

    Article  PubMed  CAS  Google Scholar 

  43. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M, Katano M (2001) Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 12:4136–4142

    Google Scholar 

  44. Schulz WA (2006) Understanding urothelial carcinoma through cancer pathways. Int J Cancer 119(7):1513–1518

    Article  PubMed  CAS  Google Scholar 

  45. Shukla S, MacLennan GT, Fu P, Patel J, Marengo SR, Resnick MI, Gupta S (2004) Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 6(4):390–400

    Article  PubMed  CAS  Google Scholar 

  46. Sobin LH, Wittekind C (1997) TNM classification of malignant tumors. Wiley, New York

    Google Scholar 

  47. Suh J, Payvandi F, Edelstein LC, Amenta PS, Zong WX, Gelinas C, Rabson AB (2002) Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate 52(3):183–200

    Article  PubMed  CAS  Google Scholar 

  48. Thanos D, Maniatis T (1995) NF-κB: a lesson in family values. Cell 80:529–532

    Article  PubMed  CAS  Google Scholar 

  49. Tojima Y, Fujimoto A, Delhase M, Chen Y, Hatakeyama S, Nakayama K, Kaneko Y, Nimura Y, Motoyama N, Ikeda K, Karin M, Nakanishi M (2000) NAK is an IkappaB kinase-activating kinase. Nature 404(6779):778–782

    Article  PubMed  CAS  Google Scholar 

  50. Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, Nigris F, Casalino L, Curcio F, Santoro M, Fusco A (1997) Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NF-κB p65 protein expression. Oncogene 15:1987–1994

    Article  PubMed  CAS  Google Scholar 

  51. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ (1999) The nuclear factor-κB/RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 5:119–127

    PubMed  CAS  Google Scholar 

  52. Wang XC, Saban R, Kaysen JS, Saban MR, Allen PL, Benes EN, Hammond TG (2000) Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder. J Urol 163(3):993–998

    Article  PubMed  CAS  Google Scholar 

  53. Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65(7):1097–1098

    Article  PubMed  CAS  Google Scholar 

  54. Xie DH, Tang XD, Xia SJ, Tan JM, Wang XH, Cai Y (2002) Expression of NF-kappa B in human bladder cancer and its clinical significance. Ai Zheng 21(6):663–667

    PubMed  Google Scholar 

  55. Zhang J, Peng B, Chen X (2005) Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 20:7334–7343

    Article  CAS  Google Scholar 

  56. Zhang PL, Pellitteri PK, Law A, Gilroy PA, Wood GC, Kennedy TL, Blasick TM, Lun M, Schuerch C 3rd, Brown RE (2005) Overexpression of phosphorylated nuclear factor- kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis. Mod Pathol 7:924–932

    Article  CAS  Google Scholar 

  57. Zhang Z, Ma J, Li N, Sun N, Wang C (2006) Expression of nuclear factor-kappaB and its clinical significance in non small-cell lung cancer. Ann Thorac Surg 1:243–248

    Article  Google Scholar 

Download references

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Athens, 11527, Greece

    Georgia Levidou, Angelica A. Saetta, Penelope Korkolopoulou, Polyanthi Papanastasiou, Katerina Gioti, Petros Pavlopoulos, Kalliopi Diamantopoulou, Eupthemia Thomas-Tsagli, Konstantinos Xiromeritis & Efstratios Patsouris

Authors
  1. Georgia Levidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angelica A. Saetta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Penelope Korkolopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Polyanthi Papanastasiou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katerina Gioti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Petros Pavlopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kalliopi Diamantopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eupthemia Thomas-Tsagli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Konstantinos Xiromeritis
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Efstratios Patsouris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georgia Levidou.

Additional information

Georgia Levidou, Angelica A. Saetta, Penelope Korkolopoulou have equally contributed to the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levidou, G., Saetta, A.A., Korkolopoulou, P. et al. Clinical significance of nuclear factor (NF)-κB levels in urothelial carcinoma of the urinary bladder. Virchows Arch 452, 295–304 (2008). https://doi.org/10.1007/s00428-007-0560-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-007-0560-y

Keywords

Search

Navigation